O'Shaughnessy Asset Management’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Sell
2,622
-1,347
-34% -$127K ﹤0.01% 1941
2026
Q1
$353K Buy
3,969
+1,545
+64% +$159K ﹤0.01% 1703
2025
Q4
$231K Sell
2,424
-277
-10% -$27.9K ﹤0.01% 1917
2025
Q3
$266K Sell
2,701
-126
-4% -$13.5K ﹤0.01% 1811
2025
Q2
$301K Sell
2,827
-475
-14% -$48K ﹤0.01% 1629
2025
Q1
$301K Sell
3,302
-4,298
-57% -$481K ﹤0.01% 1581
2024
Q4
$866K Buy
7,600
+1,373
+22% +$157K 0.01% 1020
2024
Q3
$748K Sell
6,227
-726
-10% -$66.7K 0.01% 1040
2024
Q2
$559K Buy
6,953
+966
+16% +$88.3K 0.01% 1082
2024
Q1
$552K Sell
5,987
-196
-3% -$18.8K 0.01% 1056
2023
Q4
$653K Sell
6,183
-521
-8% -$52.5K 0.01% 904
2023
Q3
$728K Buy
6,704
+857
+15% +$94.8K 0.01% 791
2023
Q2
$631K Sell
5,847
-283
-5% -$31.8K 0.01% 792
2023
Q1
$764K Buy
6,130
+2,818
+85% +$387K 0.01% 739
2022
Q4
$498K Buy
+3,312
New +$510K 0.01% 797

Other funds holding BNTX

O'Shaughnessy Asset Management's BNTX Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its BioNTech (BNTX) stake by 34% in Q2 2026, selling an estimated $127K and leaving 2,622 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #1941.

O'Shaughnessy Asset Management first reported a position in BNTX in Q4 2022 and has held it in 15 quarters since. The position peaked at $866K in Q4 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • O'Shaughnessy Asset Management held 2,622 shares of BioNTech worth $244K as of Q2 2026.
  • O'Shaughnessy Asset Management sold 1,347 BioNTech shares in Q2 2026, an estimated $127K.
  • BioNTech made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1941 holding.
  • O'Shaughnessy Asset Management first reported a position in BioNTech in Q4 2022 and has held it in 15 quarters since.
  • O'Shaughnessy Asset Management's BioNTech position peaked at $866K in Q4 2024.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.